blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0865290

EP0865290 - PHARMACEUTICAL COMPOSITIONS FOR ORAL USE INCLUDING AN NSAID AND CERAMIDES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  07.01.2005
Database last updated on 18.09.2024
Most recent event   Tooltip04.01.2008Lapse of the patent in a contracting state
New state(s): IT, PT
published on 06.02.2008  [2008/06]
Applicant(s)For all designated states
SANOFI-SYNTHELABO
174, Avenue de France
75013 Paris / FR
[2004/10]
Former [1999/45]For all designated states
Sanofi-Synthélabo
174, Avenue de France
75013 Paris / FR
Former [1998/39]For all designated states
SYNTHELABO
22, Avenue Galilée
92350 Le Plessis Robinson / FR
Inventor(s)01 / FINIDORI, Claudine
110, rue de Bagneux
F-92120 Montrouge / FR
[1998/39]
Representative(s)Thouret-Lemaitre, Elisabeth, et al
Sanofi
Département Brevets
54, rue La Boétie
75008 Paris / FR
[N/P]
Former [1998/39]Thouret-Lemaitre, Elisabeth, et al
SYNTHELABO, Département Brevets, 22 avenue Galilée
92350 Le Plessis Robinson / FR
Application number, filing date96941107.304.12.1996
[1998/39]
WO1996FR01925
Priority number, dateFR1995001439206.12.1995         Original published format: FR 9514392
[1998/39]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9720572
Date:12.06.1997
Language:FR
[1997/25]
Type: A1 Application with search report 
No.:EP0865290
Date:23.09.1998
Language:FR
The application published by WIPO in one of the EPO official languages on 12.06.1997 takes the place of the publication of the European patent application.
[1998/39]
Type: B1 Patent specification 
No.:EP0865290
Date:03.03.2004
Language:FR
[2004/10]
Search report(s)International search report - published on:EP12.06.1997
ClassificationIPC:A61K35/78, // (A61K35/78, 31:415),(A61K35/78, 31:19, A61P1:02)
[2003/32]
CPC:
A61K8/4946 (EP,US); A61K36/00 (EP,US); A61K8/365 (EP,US);
A61K8/68 (EP,US); A61P1/00 (EP); A61P1/02 (EP);
A61P29/00 (EP); A61Q11/00 (EP,US) (-)
C-Set:
A61K36/00, A61K2300/00 (EP,US)
Former IPC [1998/39]A61K35/78, // (A61K35/78, 31:415),(A61K35/78, 31:19)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   NL,   PT,   SE [1998/39]
TitleGerman:BUKKALES ARZNEIMITTEL, WELCHES EIN NSAID UND CERAMIDE ENTHÄLT[1998/39]
English:PHARMACEUTICAL COMPOSITIONS FOR ORAL USE INCLUDING AN NSAID AND CERAMIDES[1998/39]
French:COMPOSITIONS PHARMACEUTIQUES POUR APPLICATION BUCCALE COMPRENANT UN NSAID ET DES CERAMIDES[1998/39]
Entry into regional phase06.07.1998National basic fee paid 
06.07.1998Designation fee(s) paid 
06.07.1998Examination fee paid 
Examination procedure12.04.1997Request for preliminary examination filed
International Preliminary Examining Authority: EP
06.07.1998Examination requested  [1998/39]
11.06.2001Despatch of a communication from the examining division (Time limit: M04)
11.07.2001Reply to a communication from the examining division
23.04.2002Despatch of a communication from the examining division (Time limit: M06)
24.10.2002Reply to a communication from the examining division
23.07.2003Communication of intention to grant the patent
02.12.2003Fee for grant paid
02.12.2003Fee for publishing/printing paid
Opposition(s)06.12.2004No opposition filed within time limit [2005/08]
Fees paidRenewal fee
18.12.1998Renewal fee patent year 03
27.12.1999Renewal fee patent year 04
28.12.2000Renewal fee patent year 05
27.12.2001Renewal fee patent year 06
23.12.2002Renewal fee patent year 07
29.12.2003Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.03.2004
FI03.03.2004
GB03.03.2004
IE03.03.2004
IT03.03.2004
NL03.03.2004
DK03.06.2004
GR03.06.2004
SE03.06.2004
DE04.06.2004
ES14.06.2004
PT03.08.2004
LU04.12.2004
[2008/06]
Former [2007/17]AT03.03.2004
FI03.03.2004
GB03.03.2004
IE03.03.2004
NL03.03.2004
DK03.06.2004
GR03.06.2004
SE03.06.2004
DE04.06.2004
ES14.06.2004
LU04.12.2004
Former [2005/18]AT03.03.2004
FI03.03.2004
GB03.03.2004
IE03.03.2004
NL03.03.2004
DK03.06.2004
GR03.06.2004
SE03.06.2004
DE04.06.2004
ES14.06.2004
Former [2005/14]AT03.03.2004
FI03.03.2004
GB03.03.2004
IE03.03.2004
NL03.03.2004
GR03.06.2004
SE03.06.2004
DE04.06.2004
ES14.06.2004
Former [2005/05]AT03.03.2004
FI03.03.2004
GB03.03.2004
IE03.03.2004
NL03.03.2004
GR03.06.2004
SE03.06.2004
ES14.06.2004
Former [2005/03]AT03.03.2004
FI03.03.2004
GB03.03.2004
IE03.03.2004
GR03.06.2004
SE03.06.2004
ES14.06.2004
Former [2005/01]AT03.03.2004
FI03.03.2004
GB03.03.2004
GR03.06.2004
SE03.06.2004
ES14.06.2004
Former [2004/46]AT03.03.2004
FI03.03.2004
GR03.06.2004
SE03.06.2004
ES14.06.2004
Former [2004/43]AT03.03.2004
FI03.03.2004
GR03.06.2004
SE03.06.2004
Former [2004/41]FI03.03.2004
GR03.06.2004
SE03.06.2004
Former [2004/40]FI03.03.2004
SE03.06.2004
Cited inInternational search[A]WO9309805  (INOCOSM LAB [FR]) [A] 1-8 * page 9, lines 11-14 ** claim 1 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.